Proathlete Wealth Management’s Morgan Stanley MS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$699K Buy
3,343
+10
+0.3% +$1.98K 0.17% 39
2026
Q1
$549K Buy
3,333
+13
+0.4% +$2.25K 0.15% 42
2025
Q4
$590K Buy
3,320
+37
+1% +$6.17K 0.16% 39
2025
Q3
$522K Buy
3,283
+14
+0.4% +$2.07K 0.15% 42
2025
Q2
$461K Buy
3,269
+14
+0.4% +$1.72K 0.15% 44
2025
Q1
$380K Buy
3,255
+12
+0.4% +$1.55K 0.14% 48
2024
Q4
$408K Buy
3,243
+13
+0.4% +$1.6K 0.15% 46
2024
Q3
$337K Sell
3,230
-38
-1% -$3.83K 0.14% 49
2024
Q2
$318K Buy
3,268
+268
+9% +$25.5K 0.15% 49
2024
Q1
$282K Buy
3,000
+19
+0.6% +$1.67K 0.15% 49
2023
Q4
$278K Buy
+2,981
New +$238K 0.16% 46

Other funds holding MS

Proathlete Wealth Management's MS Position: Q2 2026 in Review

Proathlete Wealth Management increased its Morgan Stanley (MS) stake by 0.3% in Q2 2026, buying an estimated $1.98K and bringing the position to 3,343 shares worth $699K. The position accounts for 0.17% of the portfolio, ranked #39.

Proathlete Wealth Management first reported a position in MS in Q4 2023 and has held it in 11 quarters since. 961 funds tracked by Wall St. Rank hold MS as of Q2 2026.

  • Proathlete Wealth Management held 3,343 shares of Morgan Stanley worth $699K as of Q2 2026.
  • Proathlete Wealth Management bought 10 Morgan Stanley shares in Q2 2026, an estimated $1.98K.
  • Morgan Stanley made up 0.17% of Proathlete Wealth Management's portfolio in Q2 2026, its #39 holding.
  • Proathlete Wealth Management first reported a position in Morgan Stanley in Q4 2023 and has held it in 11 quarters since.
  • 961 funds tracked by Wall St. Rank held Morgan Stanley as of Q2 2026.

Based on Proathlete Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.